Table 4b.
Concurrent validity across administration modalities – Condition 2 (PDA/Paper)
| Measure | Paper: Mean (S.D.) | PDA: Mean (S.D.) | N1 | ICC (C.I.) |
| IPSS | 10.88 (7.5) | 9.08 (6.41) | 53 | 0.82 (0.707–0.892) |
| IIEF-5 | 11.18 (7.5) | 12.27 (8.48) | 39 | 0.86 (0.751–0.923) |
| PORPUS | ||||
| Pain | 0.47 (0.72) | 0.46 (0.75) | 52 | 0.696 (0.524–0.814) |
| Energy | 1.46 (0.95) | 1.36 (0.96) | 53 | 0.88 (0.800–0.929) |
| Social support | 0.33 (0.86) | 0.32 (0.85) | 53 | 0.987 (0.977–0.992) |
| Communication with doctor | 0.47 (0.70) | 0.36 (0.65) | 53 | 0.922 (0.868–0.954) |
| Emotional well-being | 0.86 (0.97) | 0.90 (0.93) | 52 | 0.958 (0.928–0.976) |
| Urinary frequency/urgency | 1.24 (0.97) | 0.92 (0.9) | 52 | 0.723 (0.562–0.831) |
| Leaking urine | 1.1 (1.27) | 0.87 (1.1) | 52 | 0.869 (0.782–0.923) |
| Sexual function | 2.19 (1.59) | 2.17 (1.57) | 46 | 0.992 (0.985–0.995) |
| Sexual interest | 2.02 (1.53) | 1.85 (1.63) | 47 | 0.93 (0.878–0.961) |
| Bowel problems | 0.52 (0.78) | 0.39 (0.64) | 50 | 0.878 (0.794–0.929) |
*All correlations are significant at p ≤ 0.01